Evidence map›Paper›PMID 22874564›Full record

ArticleAutophagy2012

Activation of the macroautophagic system in scrapie-infected experimental animals and human genetic prion diseases.

Yin Xu, Chan Tian, Shao-Bin Wang, Wu-Ling Xie, Yan Guo, Jin Zhang, Qi Shi, Cao Chen, Xiao-Ping Dong

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Diminished Neuronal ESCRT-0 Function Exacerbates AMPA Receptor Derangement and Accelerates Prion-Induced Neurodegeneration.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Impairment of autophagy in scrapie-infected transgenic mice at the clinical stage.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  12. An Update on Autophagy in Prion Diseases.Frontiers in bioengineering and biotechnology · 2020
    Review
  13. Article
  14. Autophagy pathways in the treatment of prion diseases.Current opinion in pharmacology · 2019
    Review
  15. Cellular and Molecular Mechanisms of Prion Disease.Annual review of pathology · 2019
    Review
  16. Article
  17. Lysosomal Quality Control in Prion Diseases.Molecular neurobiology · 2018
    Review
  18. What Is Our Current Understanding of PrPPathogens (Basel, Switzerland) · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yin XuState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chan Tian
Shao-Bin Wang
Wu-Ling Xie
Yan Guo
Jin Zhang
Qi Shi
Cao Chen
Xiao-Ping Dong
State Key Laboratory of Infectious Disease Prevention and ControlChinese Center For Disease Control and Prevention · CNIndiana University School of MedicineNational Institute for Communicable Disease Control and Prevention · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macroautophagy is an important process for removing misfolded and aggregated protein in cells, the dysfunction of which has been directly linked to an increasing number of neurodegenerative disorders. However, the details of macroautophagy in prion diseases remain obscure. Here we demonstrated that in the terminal stages of scrapie strain 263K-infected hamsters and human genetic prion diseases, the microtubule-associated protein 1 light chain 3 (LC3) was converted from the cytosolic form to the autophagosome-bound membrane form. Macroautophagy substrate sequestosome 1 (SQSTM1) and polyubiquitinated proteins were downregulated in the brains of sick individuals, indicating enhanced macroautophagic protein degradation. The levels of mechanistic target of rapamycin (MTOR) and phosphorylated MTOR (p-MTOR) were significantly decreased, which implies that this enhancement of the macroautophagic response is likely through the MTOR pathway which is a negative regulator for the initiation of macroautophagy. Dynamic assays of the autophagic system in the brains of scrapie experimental hamsters after inoculation showed that alterations of the autophagic system appeared along with the deposits of PrP(Sc) in the infected brains. Immunofluorescent assays revealed specific staining of autophagosomes in neurons that were not colocalized with deposits of PrP(Sc) in the brains of scrapie infected hamsters, however, autophagosome did colocalize with PrP(Sc) in a prion-infected cell line after treatment with bafilomycin A(1). These results suggest that activation of macroautophagy in brains is a disease-correlative phenomenon in prion diseases.

Indexed as

AutophagyAdaptor Proteins, Signal TransducingAnimalsBiomarkersBrainCricetinaeDisease Models, AnimalFemaleHumansMacrolidesMembrane ProteinsMicrotubule-Associated ProteinsMiddle AgedModels, BiologicalNeuronsPhagosomesAdaptor Proteins, Signal Transducingbafilomycin ABiomarkersMacrolidesMembrane ProteinsMicrotubule-Associated ProteinsPhosphatidylinositol 3-KinasesPrPSc ProteinsTOR Serine-Threonine KinasesUbiquitinated Proteinsautophagyneurodegenerative diseasestransmissible spongiform encephalopathies

Identifiers

PMID22874564
PMCPMC3494590
OpenAlexW2086876599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.